Medical & Research Laboratories

TD2 Expands Preclinical and Clinical Services by Acquiring Flow Contract Site Laboratory (FCSL)

Translational Drug Development (TD2), a leading provider of comprehensive preclinical drug development, translational and clinical trial services, is pleased to announce its acquisition of Flow Contract Site Laboratory (FCSL) located in Bothell, Washington. This strategic move strengthens TD2’s oncology ecosystem, enhancing its capabilities in flow cytometry and cell-based assays. The acquisition of FCSL reaffirms TD2’s […]

TD2 Expands Preclinical and Clinical Services by Acquiring Flow Contract Site Laboratory (FCSL) Read More »

Hudson Robotics and Art Robbins Instruments Strengthens Portfolio with Acquisition of Tomtec Inc.

Hudson Robotics and Art Robbins Instruments (“Hudson” or “HR”), a global laboratory automation solutions provider, and Argosy Healthcare Partners portfolio company, has acquired Tomtec Inc. (“Tomtec”). Tomtec is a provider of automated liquid handling instruments primarily used for sample preparation in mass spectrometry. The transaction expands Hudson’s liquid handling capabilities by adding an additional 96-head

Hudson Robotics and Art Robbins Instruments Strengthens Portfolio with Acquisition of Tomtec Inc. Read More »

Medix Biochemica Acquires ViroStat

Medix Biochemica, a global leader in the supply of critical raw materials to the in vitro diagnostics industry, has acquired 100 percent of the shares of ViroStat. As a result of the partnership, Medix Biochemica will be able to provide its customers with market-leading infectious disease antibodies and antigens for their IVD immunoassay test development.

Medix Biochemica Acquires ViroStat Read More »

Bruker Completes Acquisition of PhenomeX

Bruker Corporation (Nasdaq: BRKR) announces that it has completed the acquisition of PhenomeX, a leading provider of single-cell biology research tools, for $108 million in cash. Bruker announced the agreement to acquire PhenomeX on August 17, 2023. PhenomeX is a functional cell biology company that provides single-cell biology research tools to deliver deep insights into

Bruker Completes Acquisition of PhenomeX Read More »

LabShares Acquired by Life Sciences Industry Veteran Philip Borden and Pacific Lake Partners

LabShares, a leading provider of shared laboratory facilities, advanced equipment, and associated services for life science and biotech customers, has announced that life sciences industry veteran Philip Borden and investor Pacific Lake Partners have acquired a majority stake in the company. LabShares was founded in 2018 and completed a major expansion in 2022. It currently

LabShares Acquired by Life Sciences Industry Veteran Philip Borden and Pacific Lake Partners Read More »

Scroll to Top